国际口腔医学杂志 ›› 2019, Vol. 46 ›› Issue (1): 30-36.doi: 10.7518/gjkq.2019.01.006
摘要:
生理状态下,骨吸收与骨形成过程的动态平衡对维持骨组织功能至关重要。而在骨损伤状态下,如何通过促进骨形成,抑制骨吸收从而促进骨愈合过程一直是该领域研究的热点。近年来,受体活性修饰蛋白-1(RAMP1)在骨代谢过程中的调节作用已受到越来越多的关注。RAMP1广泛存在于骨组织中,它可以与不同的G蛋白偶联受体(GPCR)结合,修饰受体行为,调节相应的配体作用。此外,它还能进一步参与到受体介导的信号转导中,影响成骨相关细胞内蛋白的相互作用,从而影响成骨相关细胞增殖、迁移、分化等生物学特性。本文就近年来RAMP1促进成骨作用的研究作一综述。
中图分类号:
[1] |
Wang LP, Shi XY, Zhao R , et al. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone re-sorption[J]. Bone, 2010,46(5):1369-1379.
doi: 10.1016/j.bone.2009.11.029 pmid: 2854244 |
[2] |
Cooper RR . Nerves in cortical bone[J]. Science, 1968,160(3825):327-328.
doi: 10.1126/science.160.3825.327 |
[3] |
Bjurholm A, Kreicbergs A, Brodin E , et al. Subs-tance P- and CGRP-immunoreactive nerves in bone[J]. Peptides, 1988,9(1):165-171.
doi: 10.1016/0196-9781(88)90023-x pmid: 2452430 |
[4] |
Bahney CS, Hu DP, Taylor AJ , et al. Stem cell-derived endochondral cartilage stimulates bone hea-ling by tissue transformation[J]. J Bone Miner Res, 2014,29(5):1269-1282.
doi: 10.1002/jbmr.2148 pmid: 24259230 |
[5] |
Zhang ZM, Dickerson IM, Russo AF . Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells[J]. Endocrinology, 2006,147(4):1932-1940.
doi: 10.1210/en.2005-0918 pmid: 16373421 |
[6] |
Zhang ZM, Winborn CS, Marquez de Prado B , et al. Sensitization of calcitonin gene-related peptide re-ceptors by receptor activity-modifying protein-1 in the trigeminal ganglion[J]. J Neurosci, 2007,27(10):2693-2703.
doi: 10.1523/JNEUROSCI.4542-06.2007 pmid: 17344407 |
[7] |
Zhang YF, Xu JK, Ruan YC , et al. Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats[J]. Nat Med, 2016,22(10):1160-1169.
doi: 10.1038/nm.4162 pmid: 27571347 |
[8] |
Hay DL, Walker CS . CGRP and its receptors[J]. Headache, 2017,57(4):625-636.
doi: 10.1111/head.2017.57.issue-4 |
[9] |
Blixt FW, Radziwon-Balicka A, Edvinsson L , et al. Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina[J]. Exp Eye Res, 2017,161:124-131.
doi: 10.1016/j.exer.2017.06.002 pmid: 28603014 |
[10] |
Zheng LF, Wang R, Xu YZ , et al. Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve in-juries[J]. Brain Res, 2008,1187:20-32.
doi: 10.1016/j.brainres.2007.10.044 pmid: 18035338 |
[11] |
Toth CC, Willis D, Twiss JL , et al. Locally synthe-sized calcitonin gene-related peptide has a critical role in peripheral nerve regeneration[J]. J Neuro-pathol Exp Neurol, 2009,68(3):326-337.
doi: 10.1097/NEN.0b013e31819ac71b pmid: 19225405 |
[12] |
Xiang L, Ma L, Wei N , et al. Effect of lentiviral vector overexpression α-calcitonin gene-related peptide on titanium implant osseointegration in α-CGRP-de-ficient mice[J]. Bone, 2017,94:135-140.
doi: 10.1016/j.bone.2015.08.009 |
[13] |
Hilairet S, Foord SM, Marshall FH , et al. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins[J]. J Biol Chem, 2001,276(31):29575-29581.
doi: 10.1074/jbc.M102722200 pmid: 11387328 |
[14] |
Hay DL, Poyner DR, Smith DM . Desensitisation of adrenomedullin and CGRP receptors[J]. Regul Pept, 2003,112(1/2/3):139-145.
doi: 10.1016/S0167-0115(03)00032-6 pmid: 12667635 |
[15] |
Udawela M, Hay DL, Sexton PM . The receptor activity modifying protein family of G protein coupled re-ceptor accessory proteins[J]. Semin Cell Dev Biol, 2004,15(3):299-308.
doi: 10.1016/j.semcdb.2003.12.019 pmid: 15125893 |
[16] |
Qi T, Hay DL . Structure-function relationships of the N-terminus of receptor activity-modifying proteins[J]. Br J Pharmacol, 2010,159(5):1059-1068.
doi: 10.1111/j.1476-5381.2009.00541.x pmid: 20015292 |
[17] |
Booe JM, Walker CS, Barwell J , et al. Structural basis for receptor activity-modifying protein-depen-dent selective peptide recognition by a G protein-coupled receptor[J]. Mol Cell, 2015,58(6):1040-1052.
doi: 10.1016/j.molcel.2015.04.018 pmid: 4504005 |
[18] |
Hay DL, Walker CS, Gingell JJ , et al. Receptor activity-modifying proteins; multifunctional G pro-tein-coupled receptor accessory proteins[J]. Biochem Soc Trans, 2016,44(2):568-573.
doi: 10.1042/BST20150237 pmid: 27068971 |
[19] |
Klein KR, Matson BC, Caron KM . The expanding repertoire of receptor activity modifying protein (RAMP) function[J]. Crit Rev Biochem Mol Biol, 2016,51(1):65-71.
doi: 10.3109/10409238.2015.1128875 |
[20] |
Yuan J, Gilbert ER, Cline MA . The central anore-xigenic mechanism of amylin in Japanese quail (Coturnix japonica) involves pro-opiomelanocortin, calcitonin receptor, and the arcuate nucleus of the hypothalamus[J]. Comp Biochem Physiol A Mol Integr Physiol, 2017,210:28-34.
doi: 10.1016/j.cbpa.2017.05.011 pmid: 28552562 |
[21] |
Edvinsson L . The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine[J]. Hea-dache, 2017,57(Suppl 2):47-55.
doi: 10.1111/head.13081 pmid: 28485848 |
[22] |
Hay DL, Garelja ML, Poyner DR , et al. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25[J]. Br J Pharmacol, 2018,175(1):3-17.
doi: 10.1111/bph.14075 pmid: 29059473 |
[23] |
Booe JM, Warner ML, Roehrkasse AM , et al. Probing the mechanism of receptor activity-modifying protein modulation of GPCR ligand selectivity through rational design of potent adrenomedullin and calcitonin gene-related peptide antagonists[J]. Mol Pharmacol, 2018,93(4):355-367.
doi: 10.1124/mol.117.110916 pmid: 29363552 |
[24] |
Hay DL, Pioszak AA . Receptor activity-modifying proteins (RAMPs): new insights and roles[J]. Annu Rev Pharmacol Toxicol, 2016,56:469-487.
doi: 10.1146/annurev-pharmtox-010715-103120 pmid: 26514202 |
[25] |
Pawlak JB, Wetzel-Strong SE, Dunn MK , et al. Car-diovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice[J]. Pepti-des, 2017,88:1-7.
doi: 10.1016/j.peptides.2016.12.002 pmid: 27940069 |
[26] |
Mayr B, Montminy M . Transcriptional regulation by the phosphorylation-dependent factor CREB[J]. Nat Rev Mol Cell Biol, 2001,2(8):599-609.
doi: 10.1038/35085068 pmid: 11483993 |
[27] |
Koga T, Matsui Y, Asagiri M , et al. NFAT and Osterix cooperatively regulate bone formation[J]. Nat Med, 2005,11(8):880-885.
doi: 10.1038/nm1270 |
[28] |
Komori T . Signaling networks in RUNX2-dependent bone development[J]. J Cell Biochem, 2011,112(3):750-755.
doi: 10.1002/jcb.22994 |
[29] |
Yoo YM, Kwag JH, Kim KH , et al. Effects of neuro-peptides and mechanical loading on bone cell resorp-tion in vitro[J]. Int J Mol Sci, 2014,15(4):5874-5883.
doi: 10.3390/ijms15045874 pmid: 4013601 |
[30] |
Liang W, Zhuo XL, Tang ZF , et al. Calcitonin gene-related peptide stimulates proliferation and osteo-genic differentiation of osteoporotic rat-derived bone mesenchymal stem cells[J]. Mol Cell Biochem, 2015,402(1/2):101-110.
doi: 10.1007/s11010-014-2318-6 pmid: 25563479 |
[31] |
Mach DB, Rogers SD, Sabino MC , et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur[J]. Neuroscience, 2002,113(1):155-166.
doi: 10.1016/S0306-4522(02)00165-3 pmid: 12123694 |
[32] |
Ballica R, Valentijn K, Khachatryan A , et al. Targeted expression of calcitonin gene-related peptide to os-teoblasts increases bone density in mice[J]. J Bone Miner Res, 1999,14(7):1067-1074.
doi: 10.1359/jbmr.1999.14.7.1067 pmid: 10404006 |
[33] |
Gangula PR, Zhao H, Supowit SC , et al. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice[J]. Hyper-tension, 2000,35(1 Pt 2):470-475.
doi: 10.1161/01.HYP.35.1.470 pmid: 10642343 |
[34] |
Huebner AK, Schinke T, Priemel M , et al. Calcitonin deficiency in mice progressively results in high bone turnover[J]. J Bone Miner Res, 2006,21(12):1924-1934.
doi: 10.1359/jbmr.060820 pmid: 17002587 |
[35] |
Li Y, Tan YH, Zhang G , et al. Effects of calcitonin gene-related peptide on the expression and activity of nitric oxide synthase during mandibular bone healing in rabbits: an experimental study[J]. J Oral Maxillofac Surg, 2009,67(2):273-279.
doi: 10.1016/j.joms.2008.06.077 pmid: 19138599 |
[36] |
Hilairet S, Bélanger C, Bertrand J , et al. Agonist-pro-moted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin[J]. J Biol Chem, 2001,276(45):42182-42190.
doi: 10.1074/jbc.m107323200 pmid: 11535606 |
[37] | McLatchie LM, Fraser NJ, Main MJ , et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor[J]. Nature, 1998,393(6683):333-339. |
[38] |
Márquez-Rodas I, Xavier FE, Arroyo-Villa I , et al. Increased expression in calcitonin-like receptor in-duced by aldosterone in cerebral arteries from spon-taneously hypertensive rats does not correlate with functional role of CGRP receptor[J]. Regul Pept, 2008,146(1/2/3):125-130.
doi: 10.1016/j.regpep.2007.09.001 pmid: 17904662 |
[39] |
Togari A, Arai M, Mizutani S , et al. Expression of mRNAs for neuropeptide receptors and beta-adre-nergic receptors in human osteoblasts and human osteogenic sarcoma cells[J]. Neurosci Lett, 1997,233(2/3):125-128.
doi: 10.1016/S0304-3940(97)00649-6 |
[40] |
Kawase T, Okuda K, Burns DM . Immature human osteoblastic MG63 cells predominantly express a subtype 1-like CGRP receptor that inactivates extra-cellular signal response kinase by a cAMP-depen-dent mechanism[J]. Eur J Pharmacol, 2003,470(3):125-137.
doi: 10.1016/S0014-2999(03)01763-1 pmid: 12798950 |
[41] |
Uzan B, de Vernejoul MC, Cressent M . RAMPs and CRLR expressions in osteoblastic cells after dexame-thasone treatment[J]. Biochem Biophys Res Commun, 2004,321(4):802-808.
doi: 10.1016/j.bbrc.2004.07.037 |
[42] |
Villa I, Mrak E, Rubinacci A , et al. CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway[J]. Am J Physiol Cell Physiol, 2006,291(3):C529-C537.
doi: 10.1152/ajpcell.00354.2005 |
[43] |
Russo AF, Kuburas A, Kaiser EA , et al. A potential preclinical migraine model: CGRP-sensitized mice[J]. Mol Cell Pharmacol, 2009,1(5):264-270.
doi: 10.1186/1471-213X-8-96 pmid: 20336186 |
[44] |
Bohn KJ, Li BL, Huang XF , et al. CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1[J]. Br J Phar-macol, 2017,174(12):1826-1840.
doi: 10.1111/bph.13783 pmid: 28317098 |
[45] |
Zhao ZL, Fu XB, Zhang G , et al. The influence of RAMP1 overexpression on CGRP-induced osteo-genic differentiation in MG-63 cells in vitro: an experimental study[J]. J Cell Biochem, 2013,114(2):314-322.
doi: 10.1002/jcb.24375 pmid: 22949393 |
[46] | 蒋章, 张慧宇, 张纲 , 等. RAMP1-siRNA对CGRP促MG-63细胞增殖作用影响的实验研究[J]. 实用口腔医学杂志, 2015,31(3):339-342. |
Jiang Z, Zhang HY, Zhang G , et al. Experimental study on the effect of RAMP1-siRNA on CGRP-in-duced proliferation of MG-63 cells[J]. J Pract Stomatol, 2015,31(3):339-342. | |
[47] |
Kurashige C, Hosono K, Matsuda H , et al. Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice[J]. FASEB J, 2014,28(3):1237-1247.
doi: 10.1096/fj.13-238998 pmid: 24308973 |
[48] |
Mishima T, Ito Y, Nishizawa N , et al. RAMP1 signa-ling improves lymphedema and promotes lymphan-giogenesis in mice[J]. J Surg Res, 2017,219:50-60.
doi: 10.1016/j.jss.2017.05.124 pmid: 29078910 |
[49] |
Erdling A, Sheykhzade M, Edvinsson L . Differential inhibitory response to telcagepant on αCGRP in-duced vasorelaxation and intracellular Ca 2+ levels in the perfused and non-perfused isolated rat middle cerebral artery [J]. J Headache Pain, 2017,18(1):61.
doi: 10.1186/s10194-017-0768-4 |
[50] |
Kawashima-Takeda N, Ito Y, Nishizawa N , et al. RAMP1 suppresses mucosal injury from dextran sodium sulfate-induced colitis in mice[J]. J Gastroen-terol Hepatol, 2017,32(4):809-818.
doi: 10.1111/jgh.13505 pmid: 27513455 |
[51] |
Umeda Y, Takamiya M, Yoshizaki H , et al. Inhibition of mitogen-stimulated T lymphocyte proliferation by calcitonin gene-related peptide[J]. Biochem Biophys Res Commun, 1988,154(1):227-235.
doi: 10.1016/0006-291X(88)90674-2 pmid: 2840066 |
[52] |
Wang F, Millet I, Bottomly K , et al. Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes[J]. J Biol Chem, 1992,267(29):21052-21057.
pmid: 1383217 |
[53] | Asahina A, Hosoi J, Murphy GF , et al. Calcitonin gene-related peptide modulates Langerhans cell antigen-presenting function[J]. Proc Assoc Am Physicians, 1995,107(2):242-244. |
[54] |
Cheng L, Khan M, Mudge AW . Calcitonin gene-related peptide promotes Schwann cell prolifera-tion[J]. J Cell Biol, 1995,129(3):789-796.
doi: 10.1083/jcb.129.3.789 pmid: 7730412 |
[55] |
Ichinose M, Sawada M . Enhancement of phagocy-tosis by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages[J]. Peptides, 1996,17(8):1405-1414.
doi: 10.1016/S0196-9781(96)00198-2 pmid: 8971938 |
[56] |
Vignery A, McCarthy TL . The neuropeptide calci-tonin gene-related peptide stimulates insulin-like growth factor Ⅰ production by primary fetal rat osteo-blasts[J]. Bone, 1996,18(4):331-335.
doi: 10.1016/8756-3282(96)00017-8 pmid: 8726390 |
[57] |
He Y, Ding G, Wang X , et al. Calcitonin gene-related peptide in Langerhans cells in psoriatic plaque le-sions[J]. Chin Med J, 2000,113(8):747-751.
doi: 10.3748/wjg.v6.i5.747 pmid: 11776062 |
[58] |
Li XQ, Verge VM, Johnston JM , et al. CGRP pe-ptide and regenerating sensory axons[J]. J Neuropa-thol Exp Neurol, 2004,63(10):1092-1103.
doi: 10.1093/jnen/63.10.1092 pmid: 15535136 |
[59] | 王钊, 金丹, 陀泳华 , 等. 降钙素基因相关肽促进大鼠BMSCs迁移及VEGF的表达[J]. 中国修复重建外科杂志, 2011,25(11):1371-1376. |
Wang Z, Jin D, Tuo YH , et al. Calcitonin gene-related peptide promoting migration of rat bone marrow mesenchymal stem cells and stimulating expression of vascular endothelial growth factor[J]. Chin J Reparat Reconstruct Surg, 2011,25(11):1371-1376. | |
[60] |
Li WW, Guo TZ, Shi XY , et al. Neuropeptide re-gulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome[J]. J Neuroinflammation, 2018,15(1):105.
doi: 10.1186/s12974-018-1145-1 pmid: 29642930 |
[61] |
Héroux M, Hogue M, Lemieux S , et al. Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1[J]. J Biol Chem, 2007,282(43):31610-31620.
doi: 10.1074/jbc.M701790200 pmid: 17785463 |
[62] |
Walker CS, Eftekhari S, Bower RL , et al. A second trigeminal CGRP receptor: function and expression of the AMY1 receptor[J]. Ann Clin Transl Neurol, 2015,2(6):595-608.
doi: 10.1002/acn3.197 |
[63] |
Walker CS, Raddant AC, Woolley MJ , et al. CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured[J]. Cephalalgia, 2018,38(3):437-451.
doi: 10.1177/0333102417691762 pmid: 28165287 |
[64] |
Bühlmann N, Leuthäuser K, Muff R , et al. A recep-tor activity modifying protein (RAMP) 2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1[J]. Endocrinology, 1999,140(6):2883-2890.
doi: 10.1210/endo.140.6.6783 pmid: 10342881 |
[65] |
Pondel MD, Mould R . Cloning and transcriptional analysis of the mouse receptor activity modifying protein-1 gene promoter[J]. BMC Mol Biol, 2005,6:7.
doi: 10.1186/1471-2199-6-7 pmid: 1079840 |
[66] |
Kadmiel M, Fritz-Six KL, Caron KM . Understanding RAMPs through genetically engineered mouse models[J]. Adv Exp Med Biol, 2012,744:49-60.
doi: 10.1007/978-1-4614-2364-5 |
[67] |
Edvinsson L, Warfvinge K . Recognizing the role of CGRP and CGRP receptors in migraine and its treat-ment[J]. Cephalalgia, 2017. doi: 10.1177/0333102417736900.[Epub ahead of print].
doi: 10.1177/0333102417736900 pmid: 29020807 |
[68] |
Sexton PM, Poyner DR, Simms J , et al. Modulating receptor function through RAMPs: can they represent drug targets in themselves[J]. Drug Discov Today, 2009,14(7/8):413-419.
doi: 10.1016/j.drudis.2008.12.009 pmid: 19150656 |
[69] |
Shindo T, Tanaka M, Kamiyoshi A , et al. Regulation of cardiovascular development and homeostasis by the adrenomedullin-RAMP system[J]. Peptides, 2018. doi: 10.1016/j.peptides.2018.04.004.[Epub ahead of print].
doi: 10.1016/j.peptides.2018.04.004 pmid: 29689347 |
[1] | 陈野, 周丰, 邬琼辉, 车会凌, 李佳璇, 申佳琪, 罗恩. 脂联素对骨髓间充质干细胞的作用及其调控机制[J]. 国际口腔医学杂志, 2021, 48(1): 58-63. |
[2] | 向琳,陈晖璐,袁影,张勤,辛娜,宫苹. 降钙素基因相关肽对种植体周围神经、血管再生及骨结合的作用[J]. 国际口腔医学杂志, 2018, 45(5): 509-515. |
[3] | 伍彩娟, 杨岚, 郭吕华. 降钙素基因相关肽在骨组织再生中的作用及机制[J]. 国际口腔医学杂志, 2017, 44(4): 488-492. |
[4] | 王晨星综述 陈刚审校. 脂肪干细胞在骨组织工程中的应用进展[J]. 国际口腔医学杂志, 2011, 38(5): 550-553. |
[5] | 刘琦综述 李祖兵审校. nell-1 型基因成骨及其在骨组织工程中的应用[J]. 国际口腔医学杂志, 2011, 38(3): 364-366. |
[6] | 李灵敏,曹志中. 神经肽降钙素基因相关肽与牙周炎的关系[J]. 国际口腔医学杂志, 2008, 35(S1): -. |
[7] | 邹淑娟,陈扬熙. 机械张力对颅面骨缝成骨作用的研究进展[J]. 国际口腔医学杂志, 2005, 32(03): 172-174. |
[8] | 韩妲丽,曹志中. 龈沟液中神经肽及其与牙周炎的关系[J]. 国际口腔医学杂志, 2005, 32(02): 96-98. |
[9] | 吴昊 谢昊 . 载体对骨形成蛋白诱导成骨作用的影响[J]. 国际口腔医学杂志, 2003, 30(02): 102-104. |
[10] | 李纾,汪说之,樊明文. 表皮生长因子及其受体在牙周组织中表达的病理生理意义[J]. 国际口腔医学杂志, 2001, 28(03): -. |
[11] | 黄莉. 牙髓组织中的炎症介质[J]. 国际口腔医学杂志, 1999, 26(05): -. |
[12] | 张云飞. 正畸牙齿移动中降钙素基因相关肽的研究进展[J]. 国际口腔医学杂志, 1999, 26(02): -. |
|